A Nov. 3 event will feature presentations on Valley fever risk mitigation, vaccines, policy measures, strategies for cooperation among states and more.

Specialized cells take out the trash in the brain. When they break down, waste builds up, possibly setting the stage for Alzheimer’s disease.

Researchers at the Center for Innovation in Brain Science received a $1.4 million Translational Research in Alzheimer’s Disease and Related Dementias grant.

The startup Ancerix is working to commercialize much-needed instruments for surgical hardware removal. The team worked with Tech Launch Arizona to file patents and license its intellectual property.

For four decades, John Galgiani, MD, has pioneered translational research and clinical care for Valley fever, a disease more common in Arizona than anywhere else.

People with fibromyalgia may have another treatment option available soon thanks to continuing research at the Comprehensive Pain and Addiction Center.

Biomedical implants, such as breast implants and pacemakers, may be rejected as foreign bodies. Suppressing production of an immune protein could reduce this risk.

A new study found that the combination of chronic pain and anxiety or depression affects more than 12 million adults in the U.S.

Comprehensive Pain and Addiction Center researchers surveyed teens on both sides of the U.S.-Mexico border and found that strong family support can prevent children from using alcohol or drugs.

University of Arizona Health Sciences researchers will continue their study of green light therapy, a promising non-opioid pain relief option.